|
|
|
Volumn 3, Issue 4, 1999, Pages 348-349
|
|
Letter to the editor [2]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AUTOANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
PREDNISONE;
ADULT;
ANTIBODY TITER;
AUTOIMMUNE DISEASE;
CASE REPORT;
DISEASE SEVERITY;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
PLASMAPHERESIS;
PRIORITY JOURNAL;
SPLENECTOMY;
THROMBOCYTE COUNT;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
DOSE RESPONSE;
FOLLOW UP;
HOSPITALIZATION;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOPHYSIOLOGY;
COMBINED MODALITY THERAPY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MIDDLE AGED;
PLASMAPHERESIS;
PLATELET COUNT;
PREDNISONE;
PURPURA, THROMBOTIC THROMBOCYTOPENIC;
SEVERITY OF ILLNESS INDEX;
SPLENECTOMY;
|
|
EID: 0033218751
PISSN: 10916660
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (1)
|
|
References (2)
|
